Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
11 drugs in development
By Therapeutic Area
top 6
R&D Momentum
85/100
Pipeline Velocity
61/100
Trial Completion Rate
76/100
Pipeline Concentration
15/100
Pipeline Freshness
49/100
Strategic Signals
Activity
Last 14 days
Creating Safety in Chaos: Integrating Peer Support Workers in Emergency Departments to Support Patients Who Use Substances and Opioids
Impact of 6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics in Adults withT2D
A 3D-Printed Prosthesis Portable Station: The Vancouver Limbkit Project
Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada
Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)